News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

There's A Blood Battle Raging Between Europe's Drug Giants



11/3/2016 6:58:22 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Novo Nordisk A/S, already reeling from pricing pressure in its diabetes business, is now feeling the heat in the $8 billion market for treating hemophilia, a rare bleeding disorder.

The Danish company is bracing for competition for NovoSeven, a blockbuster that generated $1.5 billion in sales last year, from Roche Holding AG. The Swiss drugmaker is in final stages of testing a new drug that promises to chip away at a part of the market long dominated by the 20-year-old medicine.

Read at Bloomberg


comments powered by Disqus
Bloomberg
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES